Envista Holdings Corporation

NVST Healthcare Medical Instruments & Supplies

Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024. In the quarter to June 2026, revenue grew 7.10%, EPS grew 106.3%, free cash flow grew 37.6% and total debt was flat, each against the same quarter a year earlier.

22.90 0.60 −2.55%
Market cap
$3.8B
P/E
38.8×
Fwd P/E
24.4×
Dividend yield
—
F-score
7/9
Altman Z
1.59
Beneish M
−2.50
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

226.33 77.54 60.40 44.66
P/S ratio
1.29 1.34 1.48 1.49
P/FCF ratio
12.86 15.80 18.87 17.13
P/Operating CF
42.99 33.77 (1,260.04) 35.79
P/B ratio
1.10 1.17 1.35 1.39
EV/Sales
1.45 1.47 1.65 1.64
EV/EBITDA
11.14 10.78 11.68 10.94
EV/FCF
14.49 17.32 21.02 18.85
Current Ratio
2.37 2.38 2.44 2.43
Net Debt/EBITDA
3.23 2.11 3.50 2.62
Debt/Equity
0.47 0.47 0.47 0.47
Earnings Yield
0.44% 1.29% 1.66% 2.24%
Free Cash Flow Yield
7.78% 6.33% 5.30% 5.84%
Free Cash Flow per Share
0.41 0.55 (0.10) 0.65
Book value per Share
18.59 18.49 18.79 19.00
Free Cash Flow
67.90 91.70 (15.70) 105.10
EV/EBIT
20.18 18.51 19.33 17.15
Other line items

Show all line items

Columns are period end dates